Wistar rat (50 m, 50 f) |
MCPA |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 1, 4, and 16 mg/kg-d |
No oncogenicity; systemic NOEL = 4.4 mg/kg-d; LOEL 17.6 mg/kg-d |
Bellet et al. [1] |
|
B6C3F1 mice (50 m, 50 f) |
MCPA |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 20, 50, and 500 mg/kg |
No oncogenicity; systemic NOEL in females = 3.9 mg/kg-d; LOEL = 19.5 mg/kg-d; systemic NOEL in males = 15.7 mg/kg-d; LOEL = 79.5 mg/kg-d |
Bellet et al. [1] |
|
Albino rat (m, f; 25 each) |
MCPA |
Oral feeding |
Reproductive |
Two generation |
0, 2.5, 7.5, and 22.5 mg/kg-d |
Reproductive NOEL = 7.5 mg/kg-d; LOEL = 22.5 mg/kg-d |
Bellet et al. [2] |
|
Beagle dog (6 m, 6 f) |
MCPA |
Oral feeding |
chronic toxicity |
One year |
0, 0.15, 0.75, 3.75 mg/kg-d |
Effects in liver and kidney; systemic NOEL = 0.15 mg/kg-d; LOEL = 0.75 mg/kg-d |
Reported in US EPA, IRIS [175]; US EPA [3, 4] EC 2005 [30] |
|
Fischer 344 rats |
2,4-D salt |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 5, 75, and 150 mg/kg-d |
No effects; NOEL = 5 mg/kg-d |
Charles et al. [6] |
|
B6C3F1 mice |
2,4-D salt |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 5, 62.5, and 125 mg/kg-d |
No effects |
Charles et al. [6] |
|
Fischer 344 rats (m, f, 50 each) |
2,4-D acid; salt; ester |
Oral feeding |
Subchronic toxicity |
13 weeks |
0, 1, 15, 100, and 300 mg/kg-d |
NOEL = 15 mg/kg-d; statistically significant decreases in red cell mass, platelet count, T3, and T4 at 100 mg/kg-d |
Charles et al. [7] |
|
5 beagle dogs/sex/group |
2,4-D acid; salt; ester |
Oral feeding |
Chronic toxicity, oncogenicity |
One year |
0, 1, 5, and 10 mg/kg-d; 10 changed to 7.5 in yr 2 |
NOEL = 1 mg/kg-d |
Charles et al. [176] |
|
Male CD-1 mice |
salt; commercial formulation |
Drinking water |
Effect on spontaneous lymphocytic leukemia |
365 days |
0 to 50 mg/kg-d |
No effects; more control mice died than 2,4-D treated mice |
Blakley et al.[177] |
|
Male Fischer 344 rats |
salt; commercial formulation |
Oral gavage |
Immune function |
2x week for 4 weeks |
10 mg/kg |
No impact on lymphocyte blastogenesis |
Blakley et al. [178] |
|
Swiss male (6 m) |
2,4-D salt; 2,4-DCP |
Oral gavage; i.p. |
Chromosomal aberrations in bone marrow, germ cells, and sperm cells |
Three and five days |
1.7, 3.3, and 33 mg/kg |
No effects at 1.7; statistically significant chromosomal aberrations in 2/3 mice at 3.3 mg/kg and the one mouse tested at 33 mg/kg |
Amer and Aly [179] |
|
12 male CD1 mice per group |
2,4-D |
Dermal |
Bone marrow micronucleus |
1 topical application |
Approximately 110, 220, and 442 ppm |
No effect |
Schop et al. [180] |
|
13 male CD1 mice per group |
2,4-D |
Dermal |
Hair follicle nuclear aberration |
1 topical application |
Approximately 110, 220, and 442 ppm |
2% increase in nuclear aberrations at highest applied dose |
Schop et al. [180] |
|
5 per dose per group male Han Wistar rat |
2,4-D acid; salt; ester; 4 other derivatives |
Oral gavage |
In vivo unscheduled DNA synthesis |
One dose |
100, 400 ppm |
No effects observed |
Charles et al. [181] |
|
Chinese hamster |
2,4-D acid; MCPA (pure compound and commercial herbicide) |
Oral gavage |
SCE in lymphocytes |
9 days |
100 mg/kg-d |
Weak increase in SCE; not statistically significant |
Linnainmaa [19] |
|
Male Han Wistar rats |
2,4-D; MCPA |
Oral gavage |
SCE rat lymphocytes |
5 days wk for 2 weeks |
100 mg/kg-d |
No increase in SCE |
Mustonen et al. [153] |
|
Male Han Wistar rats |
2,4-D; MCPA |
Oral gavage |
SCE rat lymphocytes |
5 days wk for 2 weeks |
100 mg/kg-d |
Significantly increased peroxisome proliferation |
Mustonen et al. [153] |
|
Sprague Dawley (5 dose/group) |
2,4-D acid; MCPA (pure compound and commercial herbicide) |
Oral gavage |
SCE in rat lymphocytes |
10 days |
100, 200 mg/kg-d |
No increase in SCE |
Linnainmaa [19] |
|
Mice (5 per dose) |
2,4-D acid |
Single oral gavage |
SCE in rat lymphocytes |
1 day |
50, 100, and 200 mg/kg-d |
Statistically significant increase in SCE at 2 highest doses |
Madrigal-Bujaidar et al. [182] |
|
Osborne Wendel rats (25/dose/sex) |
2,4-D acid |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 5, 125, 625, and 1250 mg/kg-d |
No statistically significant effects |
Hansen et al. [183] |
|
Beagle dog (3/dose/sex) |
2,4-D acid |
Oral feeding |
Chronic toxicity, oncogenicity |
Two years |
0, 10, 50, 100, and 500 mg/kg-d |
No statistically significant effects |
Hansen et al. [183] |
|
Male Wistar Albino rats |
2,4-D acid; MCPA |
Oral gavage |
P450 induction |
Three days |
50, 100, and 200 mg/kg |
Significant increase in cytochrome P450 |
Bacher and Gibson [24] |
|
Male Wistar rats |
2,4-D salt; MCPA ester |
Oral feeding |
GST, GSH, and oxidation |
14 days |
1 mM/kg-d |
Weak lipid peroxidation; increase in glutathione reductase activity; increase in glutathione peroxidase for MCPA |
Hietanen et al. [184] |